Annual Report Shows Revenue & Net Income Growth, Significant Share Buybacks, and Executive Pay Cuts Amidst Declining Operating Cash Flow
Summary
Earth Science Tech reported increased revenue and net income for FY2026, alongside significant share repurchases and executive pay cuts, signaling fiscal discipline despite a notable decline in operating cash flow.
Key Events
-
Revenue and Net Income Growth
The company reported an 8% increase in revenue to $35.7 million and an 11% increase in net income to $3.6 million for the fiscal year ended March 31, 2026.
-
Significant Share Repurchases
Earth Science Tech repurchased $471,410 of common stock in FY2026 and an additional $346,359 post-period (totaling $817,769), reducing outstanding shares by over 7.1 million.
-
Executive and Director Compensation Cuts
The CEO and COO voluntarily rescinded revenue-based bonuses and variable compensation, and director fees were reduced by 50% to $2,000 per meeting, demonstrating a focus on cost control and shareholder alignment.
-
Declining Operating Cash Flow
Net cash provided by operating activities decreased significantly from $4.37 million in FY2025 to $1.94 million in FY2026, and the cash balance declined from $1.47 million to $796,797.
Analysis
Earth Science Tech's annual 10-K report reveals a mixed financial picture. While the company achieved an 8% increase in revenue and an 11% rise in net income for fiscal year 2026, operating cash flow significantly decreased by over 55% year-over-year, and the cash balance also declined. However, management demonstrated strong fiscal discipline by voluntarily reducing executive compensation and cutting director fees. The company also continued its share repurchase program, buying back over $817,000 worth of stock in FY2026 and subsequent periods, representing a notable portion of its market capitalization. Importantly, the company stated it does not anticipate needing dilutive financing for the next 12 months, which is a positive for shareholders. The CEO maintains voting control through Series B Preferred Stock, a pre-existing governance structure.
At the time of this filing, ETST was trading at $0.18 on OTC in the Life Sciences sector, with a market capitalization of approximately $52.4M. The 52-week trading range was $0.00 to $0.24. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.